Recent advances in development of amphotericin B formulations for the treatment of visceral leishmaniasis : WestminsterResearch

Publication dates
Title	Recent advances in development of amphotericin B formulations for the treatment of visceral leishmaniasis
Type	Journal article
Authors	Mohamed-Ahmed, A.H.A., Brocchini, S. and Croft, S.L.
Abstract	Purpose of review Amphotericin B (AmpB) is considered the first-line treatment for visceral leishmaniasis in areas in which resistance to antimony is prevalent. This review describes recent advances in clinically available and novel drug delivery systems of AmpB to treat visceral leishmaniasis. Recent findings Over the past two decades, lipid-based AmpB formulations developed to tackle the toxicity of AmpB have been used clinically for the treatment of visceral leishmaniasis. Liposomal AmpB (AmBisome) has been the most successful lipid formulation, and recent clinical studies on visceral leishmaniasis have shown the potential of single-dose AmBisome treatment as well as its use in short course combinations with other antileishmanial drugs. Current research is focussed on the development of more stable and affordable nonlipid formulations of AmpB. Although a diverse range of nonlipid-based AmpB formulations have been evaluated, none have yet reached the clinic. Summary Liposomal AmpB (AmBisome) has become a standard treatment, by intravenous infusion, for visceral leishmaniasis and the basis for new short course treatments. There have been extensive efforts to develop new AmpB formulations on the basis of polymers, lipids or physical aggregates of AmpB to replace the costly lipid-based formulations. However, no nonlipid-based AmpB delivery systems have yet reached the clinic.
Journal	Current Opinion in Infectious Diseases
Journal citation	25 (6), pp. 695-702
ISSN	0951-7375
	1473-6527
Year	2012
Publisher	Lippincott Williams & Wilkins
Digital Object Identifier (DOI)	https://doi.org/10.1097/qco.0b013e328359eff2
Published in print	Dec 2012

Related outputs

Management of microbial keratitis by private pharmacies in Uganda: a study of knowledge, attitude, and practice.
Abel Ebong, Simon Arunga, Tara B. Mtuy, Angela Meric Birungi, John Onyango, Gilbert Arinda, Francis Orishaba, Teddy Kwaga, Rita Kageni, David Macleod, Reena Yadav, Sandip Das Sanyam, Jeremy J. Hoffman, Abeer H.A. Mohamed Ahmed, Astrid Leck and Mathew J. Burton 2025. Management of microbial keratitis by private pharmacies in Uganda: a study of knowledge, attitude, and practice. Wellcome Open Research. 10 30. Advanced online publication.

Role of traditional healers in the management of microbial keratitis in eastern Nepal
Sandip Das Sanyam, Reena Yadav, Abeer H.A. Mohamed Ahmed, Simon Arunga, Astrid Leck, David Macleod, Abhishek Roshan, Sanjay K. Singh, Sailesh K. Mishra, Jeremy Hoffman, Matthew Burton and Tara Mtuy 2024. Role of traditional healers in the management of microbial keratitis in eastern Nepal. Wellcome Open Research. 9 295. https://doi.org/10.12688/wellcomeopenres.21241.1

Local production of eye drops in the hospital or pharmacy setting: considerations and safety tips
Mohamed-Ahmed, A.H.A. and Kuguminkiriza, D. 2023. Local production of eye drops in the hospital or pharmacy setting: considerations and safety tips. Community Eye Health. 36 (118), pp. 17-18.

Ruharo Mission Hospital eye drop production facility
Kuguminkiriza, D. and Mohamed-Ahmed, A.H.A. 2023. Ruharo Mission Hospital eye drop production facility. Community Eye Health. 36 (118), pp. 19-20.

How to prepare chlorhexidine eye drops
Mohamed-Ahmed, A.H.A., Picken, C.A.R. and Kuguminkiriza, D. 2023. How to prepare chlorhexidine eye drops. Community Eye Health. 36 (118), pp. 21-22.

Local Ugandan Production of Stable 0.2% Chlorhexidine Eye Drops
Picken, C.A.R., Brocchini, S., Burton, M.J., Blundell-Hunter, G., Kuguminkiriza, D., Kaur, H., Hoffman, J.J., Arunga, S. and Mohamed-Ahmed, A.H.A. 2023. Local Ugandan Production of Stable 0.2% Chlorhexidine Eye Drops. Translational Vision Science & Technology. 12 27. https://doi.org/10.1167/tvst.12.1.27

The impact of oral and systemic medications on the eye
Sabherwal, S. and Mohamed-Ahmed, A.H.A. 2023. The impact of oral and systemic medications on the eye. Community Eye Health. 36 (118), pp. 14-16.

Management of Filamentous Fungal Keratitis: A Pragmatic Approach
Jeremy J. Hoffman, Simon Arunga, Abeer H.A. Mohamed Ahmed, Victor Hu and Matthew Burton 2022. Management of Filamentous Fungal Keratitis: A Pragmatic Approach. Journal of Fungi. 8 (10) 1067. https://doi.org/10.3390/jof8101067

Chlorhexidine gluconate 0.2% as a treatment for recalcitrant fungal keratitis in Uganda: a pilot study.
Simon Arunga, Tumu Mbarak, Abel Ebong, James Mwesigye, Dan Kuguminkiriza, Abeer H.A. Mohamed-Ahmed, Jeremy John Hoffman, Astrid Leck, Victor Hu and Matthew Burton 2021. Chlorhexidine gluconate 0.2% as a treatment for recalcitrant fungal keratitis in Uganda: a pilot study. BMJ Open Ophthalmology. 6 e000698. https://doi.org/10.1136/bmjophth-2020-000698

How to make hand sanitiser gel
Choon Fu Goh and Abeer H.A. Mohamed Ahmed 2020. How to make hand sanitiser gel. Community Eye Health. 33 (109) 26.

How to make hand sanitiser/hand rub
Abeer H.A. Mohamed Ahmed and Choon Fu Goh 2020. How to make hand sanitiser/hand rub. Community Eye Health. 33 (109), pp. 24-25.

LC–MS analysis to determine the biodistribution of a polymer coated ilomastat ocular implant
Mohamed-Ahmed, A.H.A., Lockwood, A., Fadda, H., Madaan, S., Khaw, P.T., Brocchini, S. and Karu, K. 2018. LC–MS analysis to determine the biodistribution of a polymer coated ilomastat ocular implant. Journal of Pharmaceutical and Biomedical Analysis. 157, pp. 100-106. https://doi.org/10.1016/j.jpba.2018.05.017

Taste evaluation of a novel midazolam tablet for pediatric patients: In vitro drug dissolution, in vivo animal taste aversion and clinical taste perception profiles
Cheung, L.C., Nguyen, M., Tang, E., von Ungern Sternberg, B.S., Salman, S., Tuleu, C., Mohamed Ahmed, A.H.A., Soto, J. and Lim, L.Y. 2018. Taste evaluation of a novel midazolam tablet for pediatric patients: In vitro drug dissolution, in vivo animal taste aversion and clinical taste perception profiles. International Journal of Pharmaceutics. 535 (1-2), pp. 194-200. https://doi.org/10.1016/j.ijpharm.2017.10.060

An ilomastat-CD eye drop formulation to treat ocular scarring
Mohamed-Ahmed, A.H.A., Lockwood, A., Li, H., Bailly, M., Khaw, P.T. and Brocchini, S. 2017. An ilomastat-CD eye drop formulation to treat ocular scarring. Investigative Ophthalmology & Visual Science. 58, pp. 3425-3431. https://doi.org/10.1167/iovs.16-21377

Noncovalent complexation of amphotericin-B with poly(α-glutamic acid)
Mohamed-Ahmed, A.H.A., Les, K.A., Seifert, K., Croft, S.L. and Brocchini, S. 2017. Noncovalent complexation of amphotericin-B with poly(α-glutamic acid). Molecular Pharmaceutics. 10 (3), pp. 940-950. https://doi.org/10.1021/mp300339p

Comparative in vitro and in vivo taste assessment of liquid praziquantel formulations
Münster, M., Mohamed-Ahmed, A.H.A., Immohr, L.I., Schoch, C., Schmidt, C., Tuleu, C. and Breitkreutz, J. 2017. Comparative in vitro and in vivo taste assessment of liquid praziquantel formulations. International Journal of Pharmaceutics. 529 (1-2), pp. 310-318. https://doi.org/10.1016/j.ijpharm.2017.06.084

Quality and stability of extemporaneous pyridoxal phosphate preparations used in the treatment of paediatric epilepsy
Mohamed-Ahmed, A.H.A., Wilson, M.P., Albuera, M., Chen, T., Mills, P.B., Footitt, E.J., Clayton, P.T. and Tuleu, C. 2017. Quality and stability of extemporaneous pyridoxal phosphate preparations used in the treatment of paediatric epilepsy. Journal of Pharmacy and Pharmacology. 69 (4), pp. 480-488. https://doi.org/10.1111/jphp.12701

Principles of pharmacology in the eye
Awwad, S., Mohamed Ahmed, A.H.A., Sharma, G., Heng, J.S., Khaw, P.T., Brocchini, S. and Lockwood, A. 2017. Principles of pharmacology in the eye. British Journal of Pharmacology. 174 (23), pp. 4205-4223. https://doi.org/10.1111/bph.14024

Non-human tools for the evaluation of bitter taste in the design and development of medicines: A systematic review
Mohamed-Ahmed, A.H.A., Soto, J., Ernest, T. and Tuleu, C. 2016. Non-human tools for the evaluation of bitter taste in the design and development of medicines: A systematic review. Drug Discovery Today. 21 (7), pp. 1170-1180. https://doi.org/10.1016/j.drudis.2016.05.014

Anti-infectives
Mohamed-Ahmed, A.H.A., Ginn, C., Croft, S.L. and Brocchini, S. 2013. Anti-infectives. in: Ijeoma F. Uchegbu, Andreas G. Schätzlein, Woei Ping Cheng and Aikaterini Lalatsa (ed.) Fundamentals of Pharmaceutical Nanoscience Springer Nature. pp. 429-464

Preparation and characterisation of amphotericin B-copolymer complex for the treatment of leishmaniasis
Mohamed-Ahmed, A.H.A., Les, K.A., Croft, S.L. and Brocchini, S. 2013. Preparation and characterisation of amphotericin B-copolymer complex for the treatment of leishmaniasis. Polymer Chemistry. 4, pp. 584-591. https://doi.org/10.1039/c2py20425h

Poly(methacrylic acid) complexation of amphotericin B to treat neglected diseases
Les, K.A., Mohamed-Ahmed, A.H.A., Balan, S., Choi, J.-W., Martin, D., Yardley, V., Powell, K., Godwin, A. and Brocchini, S. 2013. Poly(methacrylic acid) complexation of amphotericin B to treat neglected diseases. Polymer Chemistry. 5, pp. 1037-1048. https://doi.org/10.1039/c3py01051a

Anti-infectives
Mohamed-Ahmed, A.H.A., Brocchini, S., Ginn, C. and Croft, S.L. 2013. Anti-infectives. in: Ijeoma F. Uchegbu,, Andreas G. Schätzlein, Woei Ping Cheng and Aikaterini Lalatsa (ed.) Fundamentals of Pharmaceutical Nanoscience Springer Nature. pp. 429-464

Antileishmanial activity, uptake, and biodistribution of an amphotericin B and poly(α-glutamic acid) complex
Mohamed-Ahmed, A.H.A., Seifert, K., Yardley, V., Burrell-Saward, H., Brocchini, S. and Croft, S.L. 2013. Antileishmanial activity, uptake, and biodistribution of an amphotericin B and poly(α-glutamic acid) complex. Antimicrobial Agents and Chemotherapy. 57 (10), pp. 4608-4614. https://doi.org/10.1128/aac.02343-12

Permalink - https://westminsterresearch.westminster.ac.uk/item/wzv27/recent-advances-in-development-of-amphotericin-b-formulations-for-the-treatment-of-visceral-leishmaniasis

Recent advances in development of amphotericin B formulations for the treatment of visceral leishmaniasis

Related outputs

Share this

Usage statistics

Export as